US 12,103,980 B2
Development of recombinant chicken IGY SCFV antibody raised against human thymidine kinase 1 expressed in prokaryotic cells and use thereof
Hu Chen, Guangdong (CN); Zuosheng Li, Guangdong (CN); Huijun Li, Guangdong (CN); Liwen Liang, Guangdong (CN); Li Dang, Guangdong (CN); Senbo Liu, Guangdong (CN); Cong Fang, Guangdong (CN); Peng Gao, Guangdong (CN); Ellen He, Guangdong (CN); Sven Isac Skog, Guangdong (CN); and Ji Zhou, Guangdong (CN)
Assigned to SINO-SWED TONGKANG BIO-TECH (SHENZHEN) LIMITED, Shenzhen (CN)
Filed by SINO-SWED TONGKANG BIO-TECH (SHENZHEN) LIMITED, Guangdong (CN)
Filed on Mar. 4, 2021, as Appl. No. 17/191,722.
Application 17/191,722 is a continuation of application No. PCT/CN2019/102620, filed on Aug. 26, 2019.
Claims priority of application No. 201811029929.1 (CN), filed on Sep. 5, 2018.
Prior Publication US 2021/0189010 A1, Jun. 24, 2021
Int. Cl. C07K 16/40 (2006.01); A61K 47/68 (2017.01)
CPC C07K 16/40 (2013.01) [A61K 47/6871 (2017.08); C07K 2317/14 (2013.01); C07K 2317/622 (2013.01); C12Y 207/01021 (2013.01); G01N 2333/9122 (2013.01)] 12 Claims
 
1. A recombinant chicken IgY scFv antibody raised against human thymidine kinase 1 and expressed in prokaryotic cells, comprising the amino acid sequence shown in SEQ ID NO: 1.